NL-OMON24538尚未招募不适用
A B2-agonist as a CFTR activator in CF Part II
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
ot applicable
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •CFTR genotype compound/A455E or compound/R117H
- •- Already had a rectal biopsy to produce an organoid
排除标准
- •- Severe acute exacerbation or pulmonary infection during last four weeks (needing intravenous treatment and/or systemic corticosteroids)
- •- Known cardiovascular medical history like cardiac failure, arrhythmias, ischemic cardiac disease, long QT interval syndrome and hypertension
研究者
相似试验
已完成
2 期
A B2-agonist as a CFTR activator in CF10083624Cystic FibrosisMucoviscidosisNL-OMON40957niversitair Medisch Centrum Utrecht10
进行中（未招募）
1 期
Bronchodilcation as a CFTR activator in CFCystic FibrosisEUCTR2014-000057-37-NLniversity Medical Centre Utrecht
进行中（未招募）
1 期
A B2-agonist as a CFTR activator in CF - Part 2Cystic fibrosisEUCTR2015-001317-28-NLMC Utrecht
已完成
不适用
A B2-agonist as a CFTR activator in CFCFTR residual function, Salbutamol, CFTR activation, personalized medicineNL-OMON21450MCU Utrecht, Prof. dr. C.K. van der Ent10
已完成
2 期
A B2-agonist as a CFTR activator in CF - Part 210083624Cystic FibrosisMucoviscidosisNL-OMON43663niversitair Medisch Centrum Utrecht14